DNA biosensors based on gold-nanoparticles-modified graphene oxide were constructed to detect two biomarkers, human epidermal growth factor receptor-2 (HER2) and the cell surface protein CD24, of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.